» Articles » PMID: 38407585

Prognostic Implication of Heart Failure Stage and Left Ventricular Ejection Fraction for Patients with In-hospital Cardiac Arrest: a 16-year Retrospective Cohort Study

Overview
Date 2024 Feb 26
PMID 38407585
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The 2022 AHA/ACC/HFSA guidelines for the management of heart failure (HF) makes therapeutic recommendations based on HF status. We investigated whether the prognosis of in-hospital cardiac arrest (IHCA) could be stratified by HF stage and left ventricular ejection fraction (LVEF).

Methods: This single-center retrospective study analyzed the data of patients who experienced IHCA between 2005 and 2020. Based on admission diagnosis, past medical records, and pre-arrest echocardiography, patients were classified into general IHCA, at-risk for HF, pre-HF, HF with preserved ejection fraction (HFpEF), and HF with mildly reduced ejection fraction or HF with reduced ejection fraction (HFmrEF-or-HFrEF) groups.

Results: This study included 2,466 patients, including 485 (19.7%), 546 (22.1%), 863 (35.0%), 342 (13.9%), and 230 (9.3%) patients with general IHCA, at-risk for HF, pre-HF, HFpEF, and HFmrEF-or-HFrEF, respectively. A total of 405 (16.4%) patients survived to hospital discharge, with 228 (9.2%) patients achieving favorable neurological recovery. Multivariable logistic regression analysis indicated that pre-HF and HFpEF were associated with better neurological (pre-HF, OR: 2.11, 95% confidence interval [CI]: 1.23-3.61, p = 0.006; HFpEF, OR: 1.90, 95% CI: 1.00-3.61, p = 0.05) and survival outcomes (pre-HF, OR: 2.00, 95% CI: 1.34-2.97, p < 0.001; HFpEF, OR: 1.91, 95% CI: 1.20-3.05, p = 0.007), compared with general IHCA.

Conclusion: HF stage and LVEF could stratify patients with IHCA into different prognoses. Pre-HF and HFpEF were significantly associated with favorable neurological and survival outcomes after IHCA. Further studies are warranted to investigate whether HF status-directed management could improve IHCA outcomes.

References
1.
Tsao C, Aday A, Almarzooq Z, Anderson C, Arora P, Avery C . Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023; 147(8):e93-e621. DOI: 10.1161/CIR.0000000000001123. View

2.
Carnicelli A, Keane R, Brown K, Loriaux D, Kendsersky P, Alviar C . Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN). Resuscitation. 2022; 183:109664. PMC: 9899313. DOI: 10.1016/j.resuscitation.2022.12.002. View

3.
Chan P, Kennedy K, Girotra S . Updating the model for Risk-Standardizing survival for In-Hospital cardiac arrest to facilitate hospital comparisons. Resuscitation. 2023; 183:109686. PMC: 9811915. DOI: 10.1016/j.resuscitation.2022.109686. View

4.
Hessulf F, Karlsson T, Lundgren P, Aune S, Stromsoe A, Sodersved Kallestedt M . Factors of importance to 30-day survival after in-hospital cardiac arrest in Sweden - A population-based register study of more than 18,000 cases. Int J Cardiol. 2018; 255:237-242. DOI: 10.1016/j.ijcard.2017.12.068. View

5.
Allencherril J, Lee P, Khan K, Loya A, Pally A . Etiologies of In-hospital cardiac arrest: A systematic review and meta-analysis. Resuscitation. 2022; 175:88-95. DOI: 10.1016/j.resuscitation.2022.03.005. View